|
RESEARCH EPOSTER SCHEDULE
|
|||||
PRESENTATION |
CATEGORY |
MONITOR |
PRESENTATION |
PRESENTATION |
ABSTRACT_TITLE |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
3:00 pm PT |
P001 |
Skin test for immediate hypersensitivity reaction to iodinated contrast media: an individual patient data meta-analysis |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
3:15 pm PT |
P002 |
13.2 mg Intranasal Epinephrine Treatment In Congestion Shows Increased Bioavailability Without Pharmacokinetic And Pharmacodynamic Correlation |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
3:30 pm PT |
P003 |
Safety of Anti-SARS-CoV-2 Monoclonal Antibody Therapies: Clinical Characteristics and Outcomes of Adverse Drug Reactions |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
3:45 pm PT |
P004 |
Impact of Angioedema on the Pharmacokinetics of Epinephrine Following Administration via Sublingual Film |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
4:00 pm PT |
P005 |
Epinephrine Administered via Sublingual Film, Manual Injection, or Auto-Injectors in Healthy Adults: Pharmacodynamic Results |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
4:15 pm PT |
P006 |
NSAID Allergy Labeling and Postpartum Opioid Utilization Following Vaginal or Cesarean Delivery |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
4:30 pm PT |
P007 |
Acute Allergic Rhinitis Increases Endogenous Epinephrine Resulting in Increased Heart Rate |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
4:45 pm PT |
P008 |
Risk Factors for Failing Penicillin Challenge Among Pediatric Patients at a Single Institution |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
5:00 pm PT |
P009 |
Factors Associated with Inequity in Penicillin Allergy Evaluation in a Single-Payer System |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
5:15 pm PT |
P010 - COMMUNITY GRANT |
Patient Perspectives on Penicillin Allergy Evaluation During Pregnancy: A Qualitative Study |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
5:30 pm PT |
P011 |
Incidence and Predictors of Cutaneous Reactions to the COVID-19 Booster Vaccine |
Friday, Nov 10 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
5:45 pm PT |
P012 |
A Single-Period, Single-Dose Study of the Pharmacokinetics of Epinephrine After Administration ARS-1 to Pediatric Subjects |
Friday, Nov 10 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
3:00 pm PT |
P030 |
Comparative Analysis of Aerobiological Rotating Impaction Devices: Rotorod vs Rotoslide |
Friday, Nov 10 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
3:15 pm PT |
P031 |
Allergic Sensitization to Inhalant Allergens in the United States |
Friday, Nov 10 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
3:30 pm PT |
P032 |
A Two Stage Artificial Intelligence (AI) Detection And Classification Model For Pollen Grain (PG) Counting. |
Friday, Nov 10 |
Allergy Diagnostics and Immunotherapy |
Monitor 21 |
3:45 pm PT |
P040 |
Briquilimab, an anti-CD117 antibody, prevents passive systemic anaphylaxis in mice expressing chimeric human/mouse CD117 |
Friday, Nov 10 |
Allergy Diagnostics and Immunotherapy |
Monitor 21 |
4:00 pm PT |
P041 |
在F过敏原致敏患者中的模式ederally Qualified Health Center |
Friday, Nov 10 |
Allergy Diagnostics and Immunotherapy |
Monitor 21 |
4:15 pm PT |
P042 |
Optimizing Utilization of Venom Immunotherapy in an Era of Venom Extract Shortages |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
3:00 pm PT |
P050 |
HAE Prophylaxis by Targeting Prekallikrein With siRNA- Phase 1 Interim Safety Outcomes and Prekallikrein Levels |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
3:15 pm PT |
P051 |
Garadacimab protects against hereditary angioedema attacks from Week 1 in pivotal Phase 3 VANGUARD study |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
3:30 pm PT |
P052 |
Healthcare Experiences Prior to Hereditary Angioedema Diagnosis in Underrepresented Racial/Ethnic Groups in the United States |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
3:45 pm PT |
P053 |
Two-Year Analysis of the Donidalorsen Phase 2 Open-Label Extension Study in Patients With Hereditary Angioedema |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
4:00 pm PT |
P054 |
Two-Year Analysis of Donidalorsen Taken Every 8 Weeks (Q8W) in Patients With Hereditary Angioedema |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
4:15 pm PT |
P055 |
Flow-Cytometry Based Immunoassay Is A Highly Sensitive Method To Quantitate Functional C1-Inhibitor In HAE Patients |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
4:30 pm PT |
P056 |
Real-World Outcomes In Patients With HAE Receiving Lanadelumab Long-Term Prophylaxis For 3 Years Or Longer |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
4:45 pm PT |
P057 |
Burden of Illness in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
5:00 pm PT |
P058 |
Bradykinin Measurement By Mass-Spectrometry Correlates With Angioedema Attack Frequency In Bradykinin-Mediated Angioedema |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
5:15 pm PT |
P059 |
Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) – A Real-World ACARE Survey |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
5:30 pm PT |
P060 |
Analysis Of Safety Data Of Remibrutinib From Completed Phase 2 Studies In Inflammatory Immune-Mediated Diseases |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 12 |
5:45 pm PT |
P061 |
Diagnostic Pathway Differences Across Physician Specialties for Patients with Chronic Spontaneous Urticaria: Real-World Survey |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
3:00 pm PT |
P072 |
Remibrutinib Provides Fast and Clinically Important Improvement of Chronic Spontaneous Urticaria Disease Activity |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
3:15 pm PT |
P073 |
Impact of Baseline Angioedema and IgE on Response to Omalizumab in Chronic Spontaneous Urticaria |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
3:30 pm PT |
P074 |
Remibrutinib Treatment Has No Impact on Blood Counts in Patients with Chronic Spontaneous Urticaria |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
3:45 pm PT |
P075 |
Dupilumab improves itch and urticaria activity across several CSU patient subpopulations: LIBERTY-CSU CUPID Study A |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
4:00 pm PT |
P076 |
Time to Sleep Improvement in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
4:15 pm PT |
P077 |
Burden on Caregivers to Pediatric Patients With Hereditary Angioedema: Results From a Multinational Survey |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
4:30 pm PT |
P078 |
Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment With Them |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
4:45 pm PT |
P079 |
Systemic Manifestations During Symptomatic Episodes In Chronic Spontaneous Urticaria: Results From The Urticaria Voices Study |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
5:00 pm PT |
P080 |
Remibrutinib Achieves Clinically Significant Response in Chronic Spontaneous Urticaria Patients Regardless of Prior Oral Treatments |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
5:15 pm PT |
P081 |
Deucrictibant immediate-release capsule reduces time to end of progression of hereditary angioedema attacks’ manifestations |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
5:30 pm PT |
P082 |
Berotralstat Reduced Attack Rates In Patients With Suspected Bradykinin-Mediated Angioedema: Real-World Outcomes |
Friday, Nov 10 |
Angioedema/Urticaria |
Monitor 13 |
5:45 pm PT |
P083 |
Association of COVID Vaccine Manufacturer to Vaccine Related Urticaria |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
3:00 pm PT |
P100 |
Wildfire-associated Increase In Reliever Use Among US Asthma Patients: Data From A Digital Health Platform |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
3:15 pm PT |
P101 |
Tezepelumab Reduces All Key Inflammatory Biomarker Levels In Patients With Severe Allergic And Eosinophilic Asthma |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
3:30 pm PT |
P102 |
Tezepelumab Reduced OCS Use In OCS-dependent Patients With Severe Asthma: Phase 3b WAYFINDER Interim Results |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
3:45 pm PT |
P103 |
Benralizumab is Effective in Reducing COPD Exacerbations in Patients with Asthma and Concomitant COPD |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
4:00 pm PT |
P104 |
Timing Of Exacerbations With Tezepelumab Versus Placebo In Patients With And Without Symptomatic Perennial Allergy |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
4:15 pm PT |
P105 |
Recent Real-World Biologic Utilization Among Adults With Severe Asthma: Data From The CHRONICLE Study |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
4:30 pm PT |
P106 |
Age, Sex, Obesity, and Controller Therapy Moderate the Relationship between Pediatric Asthma Exacerbations and COVID-19 |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
4:45 pm PT |
P107 |
Tezepelumab Efficacy In Patients With Severe Asthma By Blood Eosinophil Count And Perennial Allergy (DESTINATION) |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
5:00 pm PT |
P108 |
Statewide Burden of Asthma across the United States Between 1990-2019: Systematic and Comparative Benchmarking Study |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
5:15 pm PT |
P109 |
Unmet Educational Needs in Asthma Management Guidelines: How to Bridge the Gap? |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
5:30 pm PT |
P110 |
Primary Care Physician Referral Patterns and Awareness of Biologic Therapy for Uncontrolled Asthma |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
5:45 pm PT |
P111 |
The Effect of COVID-19 on Pediatric Asthma ICU Admissions at a Single Center. |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
3:00 pm PT |
P122 |
Heterogeneous characteristics of severe asthma patients initiating benralizumab in a real-world setting: the ZEPHYR-4 study |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
3:15 pm PT |
P123 |
Effect of the SARS-CoV-2 pandemic on pediatric asthma health-care utilization in an urban tertiary-care hospital |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
3:30 pm PT |
P124 |
Review Of Biologic Efficacy In Patients With Uncontrolled Asthma By Age At Asthma Onset |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
3:45 pm PT |
P125 |
可以继续教育准备医疗Provi吗ders to Provide Equitable Asthma Care? |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
4:00 pm PT |
P126 |
Impact of Baseline Characteristics on Long-term Response Following Omalizumab Treatment in Patients with Allergic Asthma |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
4:15 pm PT |
P127 |
Performance of the Asthma Impairment and Risk Questionnaire (AIRQ) compared to existing symptom control measures |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
4:30 pm PT |
P128 |
Adherence To Inhaled Medications In Adults With Asthma Evaluated In The ITA, Inhaler Adherence Test |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
4:45 pm PT |
P129 |
Short-acting Beta2-agonist and Systemic/Inhaled Corticosteroid Exposures in US Adolescents and Adults with Asthma |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
5:00 pm PT |
P130 |
Lower Incidence Of Hypereosinophilia With Tezepelumab Treatment Versus Placebo In The PATHWAY And NAVIGATOR Studies |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
5:15 pm PT |
P131 |
Prevalence of Asthma Attacks and Emergency Department Visits Among US Working Adults, 2020–2021 |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
5:30 pm PT |
P132 |
Optimizing School Stock Inhaler Programs for Health Equity: Using EPIS Framework and Logic Models |
Friday, Nov 10 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
5:45 pm PT |
P133 |
Digihaler System Use By Healthcare Professionals And App Connectivity In Asthma Patients: A Pragmatic Study |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
3:00 pm PT |
P150 |
Transcription Factors Impact Differentiation of T-helper Cells in Development of Endometriosis with Infertility |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
3:15 pm PT |
P151 |
Frequency of T-330G IL-2 Gene SNP in SARS-COVID-19 Patients |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
3:30 pm PT |
P152 |
Diagnostic Utility of Streptococcus Pneumonia Titers in a Single Pediatric, Tertiary Hospital and Clinic System |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
3:45 pm PT |
P153 |
Pioglitazone Restored Mouse Lung mRNA Expression of Core Clock, Inflammation and Metabolism-Related Genes |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
4:00 pm PT |
P154 |
Short-term Observation of Safety and Efficacy of Tolerogenic Dendritic Cells Use in Type-1 Diabetes Mellitus |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
4:15 pm PT |
P155 |
Membrane-bound IgE expression on plasmacytoid dendritic cells (pDCs) and B-cells across total serum IgE levels |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
4:30 pm PT |
P156 |
Reduced Bactericidal Permeability-increasing Protein is Found in Post-COVID-19 Syndrome Patients |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
4:45 pm PT |
P157 |
Young Children With Recurrent Respiratory Infections Have Inadequate Pneumococcal Antibodies |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
5:00 pm PT |
P158 |
Structural Characterization of Linear Aliphatic Amine-linked Triaryl Inhibitors of PD-1/PD-L1 With PD-L1 Dimer |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
5:15 pm PT |
P159 |
Characteristics of Disseminated Coccidioidomycosis in Pediatric Patients |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
5:30 pm PT |
P160 |
Autoimmune Disease with Skin Involvement in Patients with Common Variable Immune Deficiency in Western Ukraine |
Friday, Nov 10 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
5:45 pm PT |
P161 |
Investigating the Association between Mast Cell Activation Syndrome and Irritable Bowel Syndrome |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
3:00 pm PT |
P180 |
Efficacy and Safety of ADP101 Multifood Oral Immunotherapy in Food-Allergic Patients in the Harmony Trial |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
3:15 pm PT |
P181 |
Economic burden of food allergy is greater in households with children allergic to more foods |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
3:30 pm PT |
P182 |
Characterizing Daily Wear Time and Association with Efficacy of VP250 in the EPITOPE Study |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
3:45 pm PT |
P183-COMMUNITY GRANT |
National Needs Assessment for an Infant and Toddler Food Allergy Curriculum for Pediatric Residents |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
4:00 pm PT |
P184 |
Dupilumab Improves Outcomes in Eosinophilic Esophagitis, Regardless of History of Food Allergy or Dietary Elimination |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
4:15 pm PT |
P185 |
Investigating GI-Variant Alpha-Gal Syndrome in Pediatric Patients Diagnosed with Functional Abdominal Pain |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
4:30 pm PT |
P186 |
A Shot To Live: Anaphylaxis Curriculum Enhances Efficacy of Epinephrine Administration for Unassigned Administrators |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
4:45 pm PT |
P187 |
Understanding Perceived Determinants of Food Allergy in a US Population-Based Sample of Children and Adults |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
5:00 pm PT |
P188 |
Characteristics of an Adult Cohort with Shellfish Allergy: Comparison by Race |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
5:15 pm PT |
P189 |
Development of Tolerance In Children with Food Allergy |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
5:30 pm PT |
P190 |
Food allergy-related healthcare utilization and psychosocial burden is greater among children with more food allergies |
Friday, Nov 10 |
Food Allergy |
Monitor 17 |
5:45 pm PT |
P191 |
Predictors of the Psychosocial Burden in Parents of Food Allergic Children |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
3:00 pm PT |
P202 |
Prevalence and Incidence of Food Allergies in the US General Population |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
3:15 pm PT |
P203 |
Anaphylaxis Preparedness In Elementary Schools: Knowledge Gaps Remain Despite Frequent Training |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
3:30 pm PT |
P204 |
Significance of Serum Specific IgE Food Panel Interpretation in Identifying Potential Food Allergies in Children. |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
3:45 pm PT |
P205 |
Factors Related to Food Allergy in Asian American Children |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
4:00 pm PT |
P206 |
Racial Disparities in Allergic Disease in an Urban Pediatric Population |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
4:15 pm PT |
P207 |
Exploring the Interplay of Epinephrine and Needle Phobia: Implications and Strategies |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
4:30 pm PT |
P208 |
Eosinophilic esophagitis in children: A multicenter study in Mexico evaluating current practices |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
4:45 pm PT |
P209 |
Managing Food Allergy: Findings from a Nationwide US Survey of Practicing Allergists |
Friday, Nov 10 |
Food Allergy |
Monitor 18 |
5:00 pm PT |
P210 |
Dupilumab Is Efficacious In Patients With Eosinophilic Esophagitis Regardless Of Prior History Of Comorbidities |
Friday, Nov 10 |
Other Allergies and interaction with other disease |
Monitor 19 |
3:00 pm PT |
P225 |
Recurr患者过敏患病率高ent Pregnancy Loss |
Friday, Nov 10 |
Other Allergy Immunology Education |
Monitor 19 |
3:15 pm PT |
P226 |
Allergy Immunology Fellowship Education During COVID-19 Pandemic |
Friday, Nov 10 |
Other Atopy and COVID-19 |
Monitor 19 |
3:30 pm PT |
P227 |
Assessing Severity Of COVID-19 And The Development Of MIS-C In Pediatric Patients With Atopic Disease |
Friday, Nov 10 |
Other Biologic Therapy |
Monitor 19 |
3:45 pm PT |
P228 |
MMR and Varicella Immunization During Dupilumab Therapy |
Friday, Nov 10 |
Other Biologics, Omalizumab, Biosimilars |
Monitor 19 |
4:00 pm PT |
P229 |
Efficacy and safety of Omalizumab Biosimilar in IgE mediated diseases and multimorbidities |
Friday, Nov 10 |
Other Cannabis education for allergists |
Monitor 19 |
4:15 pm PT |
P230-COMMUNITY GRANT |
Easing the conversation: Cannabis Education for Allergists |
Friday, Nov 10 |
Other Controlled Allergen Environment |
Monitor 19 |
4:30 pm PT |
P231 |
Meta-Analysis Of In-Study Pollen Data In Environmental Exposure Chambers (EEC) From 2019-2022 Demonstrate High Reproducibility |
Friday, Nov 10 |
Other COPD |
Monitor 19 |
4:45 pm PT |
P232 |
Clinical Outcomes Among Individuals With Alpha-1 Antitrypsin Deficiency Enrolled in Medicare Advantage |
Friday, Nov 10 |
Other Drug Allergy |
Monitor 19 |
5:00 pm PT |
P233 |
Allergy to Sulfonamide Increases Risk of Pneumocystis Jiroveci Pneumonia (PJP) in Bone Marrow Transplant Patients |
Friday, Nov 10 |
Other EoE |
Monitor 19 |
5:15 pm PT |
P234 |
Efficacy of dupilumab on facilitated food introduction in Eosinophilic Esophagitis |
Friday, Nov 10 |
Other Eosinophilic Esophagitis |
Monitor 19 |
5:30 pm PT |
P235 |
Case series on the improvement of pediatric Eosinophilic Esophagitis when using Dupilumab for other indications. |
Friday, Nov 10 |
Other Eosinophilic Gastrointestinal Disease |
Monitor 19 |
5:45 pm PT |
P236 |
Characterizing Pediatric Native American Patients with Eosinophilic Gastrointestinal Disease at a Single Tertiary Care Center |
Friday, Nov 10 |
Quality Improvement |
Monitor 21 |
4:30 pm PT |
P250 |
Gender Disparities In Awards Granted by US Allergy/Immunology Societies |
Friday, Nov 10 |
Quality Improvement |
Monitor 21 |
4:45 pm PT |
P251 |
Assessing outcomes of a Dedicated Referral Pathway for Evaluation of Penicillin Allergy During Pregnancy |
Friday, Nov 10 |
Quality Improvement |
Monitor 21 |
5:00 pm PT |
P252 |
Impact of Multi-language Anaphylaxis Plans in an Outpatient Pediatric Allergy Clinic |
Friday, Nov 10 |
Quality Improvement |
Monitor 21 |
5:15 pm PT |
P253 |
Food Insecurity Screening In Food Allergic Patients |
Friday, Nov 10 |
Quality Improvement |
Monitor 21 |
5:30 pm PT |
P254 |
Self-Directed Learning in the Allergy Immunology Clinic: A Quality Improvement Project |
Friday, Nov 10 |
Quality Improvement |
Monitor 21 |
5:45 pm PT |
P255 |
Assessment Of Knowledge Of Identifying Anaphylaxis And EpiPen Usage Among Residents In A Teaching Hospital |
Friday, Nov 10 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
5:15 pm PT |
P270 |
Baseline Corticosteroid Use and Surgery History Among Patients with CRSwNP in Global AROMA registry |
Friday, Nov 10 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
5:30 pm PT |
P271 |
Baseline Disease Burden Among Patients with Chronic Rhinosinusitis with Nasal Polyps in Global AROMA Registry |
Friday, Nov 10 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
5:45 pm PT |
P272 |
Dupilumab Improves Olfaction In Patients With Chronic Rhinosinusitis With Nasal Polyps Irrespective Of Gender |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
3:00 pm PT |
P280 |
Maintenance Of Lebrikizumab Efficacy In Moderate-To-Severe Atopic Dermatitis Patients With Stable Asthma Control |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
3:15 pm PT |
P281 |
Effect of Delaying First Newborn Bath on the Prevalence of Atopic Dermatitis in Early Childhood |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
3:30 pm PT |
P282 |
Tapinarof Cream Improved Itch In Two Phase 3 Trials Of Moderate To Severe Atopic Dermatitis |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
3:45 pm PT |
P283 |
Efficacy of Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
4:00 pm PT |
P284 |
Once-Daily Roflumilast Cream 0.15% for Atopic Dermatitis: Pooled Results from INTEGUMENT-1/2 Phase 3 Trials |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
4:15 pm PT |
P285 |
Assessing Total Corticosteroid Burden in Atopic Dermatitis and Related Atopic Comorbidities |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
4:30 pm PT |
P286 |
Safety and Pharmacokinetics of IMG-007, an OX40 monoclonal antibody, in Healthy Adults |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
4:45 pm PT |
P287 |
Safety of Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis |
Friday, Nov 10 |
Skin Disorders |
Monitor 20 |
5:00 pm PT |
P288-COMMUNITY GRANT |
Asthma and Atopic Dermatitis-related Outcomes in Urban Children |
Saturday, Nov 11 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
11:35 am PT |
P013 |
Predictive Factors Of Successful Transition To Outpatient For Patients Undergoing Inpatient Desensitization To Chemotherapeutics |
Saturday, Nov 11 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
11:50 am PT |
P014 |
Observing patients with anaphylaxis in the Emergency Room: Should we have guidelines? |
Saturday, Nov 11 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
12:05 pm PT |
P015 |
The Noise About SARS-COV-2 Vaccination: A Retrospective Cohort Study Evaluating Tinnitus and Vaccination |
Saturday, Nov 11 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
12:20 pm PT |
P016 |
A Review of Pediatric Drug-Induced Anaphylaxis Reports in the FDA Adverse Event Reporting System (FAERS) |
Saturday, Nov 11 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
12:35 pm PT |
P017 |
Descriptive Analysis of Elevated Serum Tryptase in a Pediatric Cohort |
Saturday, Nov 11 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
11:35 am PT |
P033 |
Alternaria-sensitization取决于发展concurrent Malassezia sensitization demonstrating an interplay of sensitizing fungal allergens |
Saturday, Nov 11 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
11:50 am PT |
P034 |
Longitudinal Prescribing Patterns of Uncommon Mammalian Allergen Immunotherapy across the U.S. Military Healthcare System |
Saturday, Nov 11 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
12:05 pm PT |
P035 |
Assessing Vertical Airborne Pollen Disparity Using the Novel PollenEyes, a 3D-Printed Rotating Arm Impactor |
Saturday, Nov 11 |
Allergy Diagnostics and Immunotherapy |
Monitor 15 |
12:20 pm PT |
P043 |
Characterizing clinically "relevant" and "irrelevant" adverse reactions to subcutaneous polymerized house dust mite extracts immunotherapy |
Saturday, Nov 11 |
Allergy Diagnostics and Immunotherapy |
Monitor 15 |
12:35 pm PT |
P044 |
Reduced intra-subject variability of Skin Prick Automated Test to detect sensitization to inhalant allergens |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 12 |
11:35 am PT |
P062 |
Remibrutinib Did Not Impact on Total Serum Immunoglobulin Levels of Patients with Chronic Spontaneous Urticaria |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 12 |
11:50 am PT |
P063 |
Highly Sensitive Digital PCR Assay to Detect KIT D816V Mutation in Suspected Mastocytosis Patients |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 12 |
12:05 pm PT |
P064 |
Berotralstat Reduced Attack Rates Compared To Baseline In Patients With Hereditary Angioedema In Apex-S |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 12 |
12:20 pm PT |
P065 |
CRISPR/Cas9 editing of KLKB1 in Hereditary Angioedema Patients: Updated Results from a Phase 1 Study |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 12 |
12:35 pm PT |
P066 |
Support for STAR-0215 Administered Every Three- or Six-Months for Hereditary Angioedema: Phase 1a Results |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 13 |
11:35 am PT |
P084 |
Long-term quality-of-life and patient-reported improvements with garadacimab for hereditary angioedema: Phase 3 open-label extension study |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 13 |
11:50 am PT |
P085 |
Treatment Patterns Among Individuals with Hereditary Angioedema in the United States |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 13 |
12:05 pm PT |
P086 |
Real-World Quality of Life in Patients with HAE Receiving Lanadelumab or Other Long-Term Prophylaxis |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 13 |
12:20 pm PT |
P087 |
Reasons Not To Treat HAE Attacks And Satisfaction For On-Demand Treatment |
Saturday, Nov 11 |
Angioedema/Urticaria |
Monitor 13 |
12:35 pm PT |
P088 |
Remibrutinib Showed Good Stability of Response in Patients With Chronic Spontaneous Urticaria: Phase 2b Study |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
11:35 am PT |
P112 |
Efficacy and Safety of Dupilumab in Preschool Children With Atopic Dermatitis and Type 2 Comorbidities |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
11:50 am PT |
P113 |
Association between neighborhood deprivation index and asthma exacerbation and utilization among individuals with intermittent asthma |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
12:05 pm PT |
P114 |
Biologic Outcomes Among Adults with Severe Asthma by Age of Onset: Results from CHRONICLE |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
12:20 pm PT |
P115 |
Safety of As-needed Albuterol-budesonide by Background Inhaled Corticosteroid Maintenance Dose in Adults with Moderate-to-severe Asthma |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
12:35 pm PT |
P116 |
Perceptions On Use Of A Shared Decision-Making Guide Among Minoritized Patients With Asthma |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
11:35 am PT |
P134 |
Coexisting Chronic Rhinosinusitis with Nasal Polyps in Patients With Moderate-to-Severe Asthma: The RAPID registry study |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
11:50 am PT |
P135 |
Risk Factors of Asthma Exacerbations in Patients with Intermittent Asthma |
Saturday, Nov 11 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
12:05 pm PT |
P136 |
Blood Eosinophil Level Changes With Biologic Initiation: Real-world Data From The CHRONICLE Study |
Saturday, Nov 11 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
11:35 am PT |
P162 |
CD14 (C-159)T Gene Polymorphism in SARS-CoV-2 Patients in Crimea |
Saturday, Nov 11 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
11:50 am PT |
P163 |
Oxalic Acid Levels Impact Cytokine Production Leading to Greater Chronic Inflammation in Chronic Kidney Diseases |
Saturday, Nov 11 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
12:20 pm PT |
P165 |
Mortality in Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS), a Systematic Literature Review (SLR) |
Saturday, Nov 11 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
12:35 pm PT |
P166 |
Overall Survival (OS) Among Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) |
Saturday, Nov 11 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
12:05 pm PT |
P169-INTL SCHOLARSHIP AWARDEE |
Specific Antibody Defect in Bronchiectasis of Unknown Aetiology |
Saturday, Nov 11 |
Food Allergy |
Monitor 17 |
11:35 am PT |
P192 |
Parent Perspectives on Peanut Allergy Oral Immunotherapy Timing for Young Children |
Saturday, Nov 11 |
Food Allergy |
Monitor 17 |
11:50 am PT |
P193 |
Addressing the Research Participation Gap in Food Allergy |
Saturday, Nov 11 |
Food Allergy |
Monitor 17 |
12:05 pm PT |
P194 |
Why Do Those Who Need an Epinephrine Autoinjector Not Carry It?: A Customer Discovery Approach |
Saturday, Nov 11 |
Food Allergy |
Monitor 17 |
12:20 pm PT |
P195-COMMUNITY GRANT |
Adolescents demonstrate improved comfort with self-management of food allergies with implementation of tailored education visit |
Saturday, Nov 11 |
Food Allergy |
Monitor 17 |
12:35 pm PT |
P196 |
Allergist Access as a Potential Driver of Socioeconomic Disparities in Food Allergy |
Saturday, Nov 11 |
Other Eosinophilic granulomatosis with polyangiitis |
Monitor 19 |
11:35 am PT |
P237 |
Mepolizumab对伊红患者的影响ophilic Granulomatosis With Polyangiitis in the United States |
Saturday, Nov 11 |
Other Eye allergy |
Monitor 19 |
11:50 am PT |
P238 |
Allergic profile in pediatric keratoconus on a third level hospital in northeastern Mexico |
Saturday, Nov 11 |
Other Fellowship Consultation and Training |
Monitor 19 |
12:05 pm PT |
P239 |
TREC Screening Results Have Emerged as a Key Reason for Inpatient Pediatric Allergy/Immunology Consultation |
Saturday, Nov 11 |
Other Health disparity |
Monitor 19 |
12:20 pm PT |
P240 |
Language Barriers are Associated with the Underdiagnosis of Allergy and Immunology Conditions in Children |
Saturday, Nov 11 |
Other Mastocytosis |
Monitor 19 |
12:35 pm PT |
P241 |
Avapritinib Improved Gastrointestinal Symptoms in Patients With Indolent Systemic Mastocytosis: Registrational Double-Blind, Placebo-Controlled PIONEER Study |
Saturday, Nov 11 |
Quality Improvement |
Monitor 20 |
12:20 pm PT |
P258 |
Hybrid Telemedicine For Patient Care: Insights From A Patient Satisfaction Survey |
Saturday, Nov 11 |
Quality Improvement |
Monitor 20 |
12:35 pm PT |
P259 |
A Quality Improvement Initiative Increasing Formal Evaluations of Unconfirmed Penicillin Allergies in a Pediatric Hospital |
Saturday, Nov 11 |
Quality Improvement |
Monitor 21 |
12:20 pm PT |
P260 |
An Evaluation Of Outcomes In Penicillin Allergic Stem Cell Transplant Patients |
Saturday, Nov 11 |
Quality Improvement |
Monitor 21 |
12:35 pm PT |
P261 |
Assessment of Pediatrics Resident Knowledge Regarding Epinephrine Autoinjectors |
Saturday, Nov 11 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
11:35 am PT |
P273 |
Assessing the Effects of Area Deprivation Index on Outcome Measures in Patients with Chronic Rhinosinusitis |
Saturday, Nov 11 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
11:50 am PT |
P274 |
Joint Pain and Sinus Scores in 3 Populations of Aspirin-Exacerbated Respiratory Disease Patients |
Saturday, Nov 11 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
12:05 pm PT |
P275 |
Actigraphy as an Objective Measure of Sleep Disruption in Chronic Rhinosinusitis |
Saturday, Nov 11 |
Skin Disorders |
Monitor 20 |
11:35 am PT |
P289 |
Atopic Dermatitis Patient Experience With Discussing and Addressing Mental Health Concerns with Allergists |
Saturday, Nov 11 |
Skin Disorders |
Monitor 20 |
11:50 am PT |
P290 |
Allergic Diseases and Allergen Sensitization in Patients with Alopecia Areata |
Saturday, Nov 11 |
Skin Disorders |
Monitor 20 |
12:05 pm PT |
P291 |
Atopic & Inflammatory Skin Conditions Amongst People Experiencing Homelessness: Insights from Miami Street Medicine |
Sunday, Nov 12 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
11:35 am PT |
P018 |
Effect of Upper Respiratory Tract Infection on the Pharmacokinetics and Pharmacodynamics of Intranasal Epinephrine |
Sunday, Nov 12 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
11:50 am PT |
P019 |
Healthcare Disparities Investigated in an Innovative Multicenter General Pediatric Directed Pathway to Remove Penicillin Allergies |
Sunday, Nov 12 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
12:05 pm PT |
P020 |
Improving the Management of Pediatric Anaphylaxis in the Emergency Department at a Tertiary Care Hospital |
Sunday, Nov 12 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
12:20 pm PT |
P021 |
Risk Factors For Systemic Reactions In Rush Aeroallergen Immunotherapy |
Sunday, Nov 12 |
Adverse Drug Reactions, Insect Reactions, Anaphylaxis |
Monitor 11 |
12:35 pm PT |
P022 |
Outcomes of Patients with Left Ventricular Assisted Device (LVAD) and Penicillin-Allergy Label |
Sunday, Nov 12 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
11:35 am PT |
P036 |
A Breath of Fresh Information on Air Cleaning Technology |
Sunday, Nov 12 |
空气生物学、过敏原、过敏原提取物 |
Monitor 21 |
11:50 am PT |
P037 |
Health Consequences and Remediation of Mold Exposure Following Natural Disasters: A Scoping Review |
Sunday, Nov 12 |
Allergy Diagnostics and Immunotherapy |
Monitor 15 |
12:20 pm PT |
P045 |
Minimally Invasive Point of Care Total IgE Quantification is Clinically Equivalent to Laboratory Reference Standard |
Sunday, Nov 12 |
Allergy Diagnostics and Immunotherapy |
Monitor 15 |
12:35 pm PT |
P046 |
Preferred Allergy Immunotherapy Treatment and Needle Phobia Among Children with Allergic Rhinitis: Survey Results |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 12 |
11:35 am PT |
P067 |
Real-World Effectiveness of Omalizumab in Patients Treated for Chronic Spontaneous Urticaria |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 12 |
11:50 am PT |
P068 |
Perspectives of Medical Care Among Patients With Hereditary Angioedema Within Underrepresented Racial or Ethnic Groups |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 12 |
12:05 pm PT |
P069 |
Diagnosing Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) – A Real World ACARE Survey |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 12 |
12:20 pm PT |
P070 |
Refining Prevalence Estimates of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 12 |
12:35 pm PT |
P071 |
Efficacy and Safety of CT-P39 compared to Reference Omalizumab in Patients with Chronic Spontaneous Urticaria |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 13 |
11:35 am PT |
P089 |
关系ship Between D-Dimer Levels And Clinical Activity Of Spontaneous Chronic Urticaria. |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 13 |
11:50 am PT |
P090 |
Omalizumab Use in Patients with Chronic Spontaneous Urticaria: A Real-World Survey in the United States |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 13 |
12:05 pm PT |
P091 |
Burden of Hereditary Angioedema: Findings from a Multinational Survey of Caregivers for Adult Patients |
Sunday, Nov 12 |
Angioedema/Urticaria |
Monitor 13 |
12:20 pm PT |
P092 |
Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
11:35 am PT |
P117 |
Dupilumab Efficacy in Children With/Without Allergic Asthma in the Presence of Elevated Type 2 Biomarkers |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
11:50 am PT |
P118 |
Dupilumab Reduces Corticosteroid Use in Children With Uncontrolled Moderate-to-severe Asthma Regardless of Exacerbation History |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
12:05 pm PT |
P119 |
Assessment of the Immune Status in Obese Asthma Patients |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
12:20 pm PT |
P120 |
Fractional Exhaled Nitric Oxide (FeNO) is a Stable Biomarker in Patients with Uncontrolled Asthma |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 14 |
12:35 pm PT |
P121 |
Trusted Messenger Virtual Asthma Coaching Intervention Impacts Asthma Self-Management |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
11:35 am PT |
P137 |
Randomized attention-placebo controlled trial of a digital self-management platform for adult asthma |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
11:50 am PT |
P138 |
Respiratory Functions in Girls with Varying Levels of Physical Activity |
Sunday, Nov 12 |
Asthma, Other Lower Airway Disorders |
Monitor 15 |
12:05 pm PT |
P139 |
Association Between Baseline Characteristics and Oral Corticosteroid Reduction in Patients With Oral Corticosteroid-Dependent Severe Asthma |
Sunday, Nov 12 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
11:35 am PT |
P167 |
Clinical Assessment of Safety, Pharmacokinetics, and Efficacy of Immune Globulin Intravenous 10% in Pediatric Patients |
Sunday, Nov 12 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
11:50 am PT |
P168 |
SARS-CoV2 Specific Antibody Responses to COVID-19 Vaccination in Common Variable Immunodeficiency |
Sunday, Nov 12 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
12:20 pm PT |
P170 |
Long-Term Outcomes with Immune Globulin Subcutaneous 16.5% in Treatment of Primary Immunodeficiency |
Sunday, Nov 12 |
Clinical Immunology, Immunodeficiency |
Monitor 16 |
12:35 pm PT |
P171 |
Nasal Powder Methyl-cellulose Alone or with European Wild Garlic as Mucosal Barrier Against Viruses |
Sunday, Nov 12 |
Food Allergy |
Monitor 17 |
11:35 am PT |
P197 |
Using Instagram to Provide High-Quality Food Allergy Education and Awareness |
Sunday, Nov 12 |
Food Allergy |
Monitor 17 |
11:50 am PT |
P198 |
Food Allergies Associations with Anxiety and Depression Disorders in the US General Population |
Sunday, Nov 12 |
Food Allergy |
Monitor 17 |
12:05 pm PT |
P199 |
Methodology of the Cross-Sectional Study for Global Prevalence and Severity of Food Allergies (ASSESS FA) |
Sunday, Nov 12 |
Food Allergy |
Monitor 17 |
12:20 pm PT |
P200 |
Food Allergies and Autism Spectrum Disorder: A Comparative Study of Sensitization in Children. |
Sunday, Nov 12 |
Food Allergy |
Monitor 17 |
12:35 pm PT |
P201 |
Impact of dupilumab on food-specific IgE levels |
Sunday, Nov 12 |
Other Medicare Reimbursement Trends in Allergy/Immunology |
Monitor 19 |
11:35 am PT |
P242 |
Changes in Medicare Reimbursement for Allergy and Immunology Procedures: A State-by-State Analysis 2013-2022 |
Sunday, Nov 12 |
Other Medication Adherence |
Monitor 19 |
11:50 am PT |
P243 |
HealthBeacon's Injection Care Management System (ICMS); Improving Adherence to Injectable Medication for Respiratory Disease |
Sunday, Nov 12 |
Other SARS-CoV-2 infection |
Monitor 19 |
12:05 pm PT |
P244 |
Double blind randomized controlled trial of saline solution gargling and nasal rinsing in SARS-CoV-2 infection |
Sunday, Nov 12 |
Other Stomach or GI |
Monitor 19 |
12:20 pm PT |
P245 |
A Study of Dupilumab Versus Placebo in Patients With Eosinophilic Gastritis With/Without Eosinophilic Duodenitis |
Sunday, Nov 12 |
Quality Improvement |
Monitor 20 |
12:20 pm PT |
P256 |
Continued Evaluation Of Penicillin Allergy Delabeling And The Impact Of Resident Education On Current Efforts |
Sunday, Nov 12 |
Quality Improvement |
Monitor 20 |
12:35 pm PT |
P257 |
Evaluation of an Allergy and Immunology Handbook to Improve Medical Education for Fellows |
Sunday, Nov 12 |
Quality Improvement |
Monitor 21 |
12:20 pm PT |
P262 |
Building a Pediatric Drug Allergy Evaluation Program |
Sunday, Nov 12 |
Quality Improvement |
Monitor 21 |
12:35 pm PT |
P263 |
Why Tolerate Food Intolerance |
Sunday, Nov 12 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
11:35 am PT |
P276 |
Impacts of Tethered Education for Clinicians and Patients in Management of Severe Nasal Polyps (NPs) |
Sunday, Nov 12 |
Rhinitis, Other Upper Airway Disorders |
Monitor 18 |
11:50 am PT |
P277 |
Improved sleep quality and timing in patients with Chronic-rhinosinusitis after use of deep-delivery nasal corticosteroid |
Sunday, Nov 12 |
Skin Disorders |
Monitor 20 |
11:35 am PT |
P292 |
Seum IgE reduction after dupilumab therapy in patients with atopic dermatitis in southern Puerto Rico |
Sunday, Nov 12 |
Skin Disorders |
Monitor 20 |
11:50 am PT |
P293 |
Common Contact Allergens Found by Patch Testing in the Allergist’s Office |
Sunday, Nov 12 |
Skin Disorders |
Monitor 20 |
12:05 pm PT |
P294 |
Empowering People of Color (POC) with Moderate-to-severe Atopic Dermatitis to Advocate for Multidisciplinary Care |
| No FAQ Found |